08 Investments in Joint Ventures and Associates / Financial Assets
2014
Download XLS |
|
|
|
|
|||||
€ million |
Investments in joint ventures and associates accounted for using the equity method |
Investments |
Other financial assets |
Financial assets |
||||
|
|
|
|
|
||||
Acquisition or production cost |
|
|
|
|
||||
Balance as of Jan. 1, 2014 |
18.9 |
12.8 |
231.6 |
244.4 |
||||
Disposals |
– |
– |
-4.9 |
-4.9 |
||||
Changes in scope of consolidation |
– |
– |
-142.2 |
-142.2 |
||||
Changes resulting from application of the equity method |
-1.1 |
– |
– |
– |
||||
Exchange-rate differences |
2.7 |
– |
9.1 |
9.1 |
||||
Balance as of Dec. 31, 2014 |
20.5 |
12.8 |
93.6 |
106.4 |
||||
|
|
|
|
|
||||
Depreciation |
|
|
|
|
||||
Balance as of Jan. 1, 2014 |
– |
1.6 |
– |
1.6 |
||||
Balance as of Dec. 31, 2014 |
– |
1.6 |
– |
1.6 |
||||
|
|
|
|
|
||||
Carrying amounts as of Dec. 31, 2014 |
20.5 |
11.2 |
93.6 |
104.8 |
||||
|
|
|
|
|
2013
Download XLS |
|
|
|
|
|||||
€ million |
Investments in joint ventures and associates accounted for using the equity method |
Investments |
Other financial assets |
Financial assets |
||||
|
|
|
|
|
||||
Acquisition or production cost |
|
|
|
|
||||
Balance as of Jan. 1, 2013 |
41.0 |
15.4 |
256.4 |
271.8 |
||||
Disposals |
– |
-2.2 |
– |
-2.2 |
||||
Other changes |
– |
– |
12.2 |
12.2 |
||||
Changes resulting from application of the equity method |
-18.9 |
– |
-21.2 |
-21.2 |
||||
Exchange-rate differences |
-3.2 |
-0.4 |
-15.8 |
-16.2 |
||||
Balance as of Dec. 31, 2013 |
18.9 |
12.8 |
231.6 |
244.4 |
||||
|
|
|
|
|
||||
Depreciation |
|
|
|
|
||||
Balance as of Jan. 1, 2013 |
– |
2.0 |
– |
2.0 |
||||
Exchange-rate differences |
– |
-0.4 |
– |
-0.4 |
||||
Balance as of Dec. 31, 2013 |
– |
1.6 |
– |
1.6 |
||||
|
|
|
|
|
||||
Carrying amounts as of Dec. 31, 2013 |
18.9 |
11.2 |
231.6 |
242.8 |
||||
|
|
|
|
|
Negative changes of € 21.2 million resulting from application of the equity method were set off for the first time in 2013 against a loan classified as a net investment.
Further financial information on associated companies and joint ventures is contained in Note 23.